Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece. 2013

George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
University of Thessaly, School of Health Sciences, Faculty of Medicine, General University Hospital of Larissa, Biopolis, Larissa, Greece.

BACKGROUND An experimental 26-valent M protein Group A streptococcal (GAS) vaccine has entered clinical studies. Pharyngeal GAS emm type surveillances in different areas and time-periods enhance the understanding of the epidemiology of GAS pharyngitis. Moreover, these surveillances, combined with the data on GAS invasive disease, can play a significant role in the formulation of multivalent type-specific vaccines. METHODS During a 7-year period (1999-2005), 2408 GAS isolates were recovered from consecutive children with pharyngitis in Western Greece. The overall macrolide resistance rate was 22.8%. Along the study period we noted a tendency towards significantly decreased rates of resistance, with the lowest rates occurring in 2002 (15.3%), 2003 (15%) and 2004 (16.7%). A random sample of isolates from each year, 338 (61.7%) of the 548 macrolide-resistant and 205 (11%) of the macrolide-susceptible, underwent molecular analysis, including emm typing. RESULTS The 543 typed isolates had 28 different emm types. A statistically significant association was found between macrolide resistance and emm4, emm22 and emm77, whereas emm1, emm3, emm6, emm12, emm87 and emm89 were associated with macrolide susceptibility. A significant yearly fluctuation was observed in emm4, emm28 and emm77. The most common macrolide-resistant GAS were emm77 isolates harboring erm(A), either alone or in combination with mef(A), emm4 carrying mef(A), emm28 possessing erm(B), emm75 carrying mef(A), emm12 harboring mef(A) and emm22 carrying erm(A). We estimated that 82.8% of the isolates belonged to emm types included in the novel 26-valent M protein vaccine. The vaccine coverage rate was determined mainly by the increased frequency of nonvaccine emm4 isolates. CONCLUSIONS A limited number of emm types dominated among macrolide-susceptible and macrolide-resistant GAS isolates. We observed seasonal fluctuations, which were significant for emm4, emm28 and emm77. This type of data can serve as baseline information if the novel 26-valent M protein GAS vaccine is introduced into practice.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010612 Pharyngitis Inflammation of the throat (PHARYNX). Sore Throat,Pharyngitides,Sore Throats,Throat, Sore
D010614 Pharynx A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX (laryngopharynx). Throat,Pharynxs,Throats
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
July 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
March 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
June 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
April 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
March 2007, The Pediatric infectious disease journal,
George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
October 2008, Journal of medical microbiology,
George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
February 2024, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
December 2005, The Pediatric infectious disease journal,
George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
February 2020, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
George A Syrogiannopoulos, and Ioanna N Grivea, and Adnan Al-Lahham, and Maria Panagiotou, and Alexandra G Tsantouli, and Aspasia N Michoula Ralf René Reinert, and Mark van der Linden
September 2022, Open forum infectious diseases,
Copied contents to your clipboard!